Literature DB >> 22869273

Carbapenem-resistant enterobacteriaceae: a statewide survey of detection in Massachusetts hospitals.

Evangeline Thibodeau1, Robert Duncan, David R Snydman, Barbara Bolstorff, Johanna Vostok, Kerri Barton, Alfred Demaria.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22869273      PMCID： PMC4034447          DOI： 10.1086/667377

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN： 0899-823X            Impact factor:   3.254


× No keyword cloud information.
  6 in total

1.  Klebsiella pneumoniae carbapenemase-producing organisms: an ounce of prevention really is worth a pound of cure.

Authors:  Arjun Srinivasan; Jean B Patel
Journal:  Infect Control Hosp Epidemiol       Date:  2008-12       Impact factor: 3.254

Review 2.  Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention.

Authors:  Neil Gupta; Brandi M Limbago; Jean B Patel; Alexander J Kallen
Journal:  Clin Infect Dis       Date:  2011-07-01       Impact factor: 9.079

3.  Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae.

Authors:  H Yigit; A M Queenan; G J Anderson; A Domenech-Sanchez; J W Biddle; C D Steward; S Alberti; K Bush; F C Tenover
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

Review 4.  The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria.

Authors:  Patrice Nordmann; Gaelle Cuzon; Thierry Naas
Journal:  Lancet Infect Dis       Date:  2009-04       Impact factor: 25.071

5.  NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007.

Authors:  Alicia I Hidron; Jonathan R Edwards; Jean Patel; Teresa C Horan; Dawn M Sievert; Daniel A Pollock; Scott K Fridkin
Journal:  Infect Control Hosp Epidemiol       Date:  2008-11       Impact factor: 3.254

6.  Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies.

Authors:  Gopi Patel; Shirish Huprikar; Stephanie H Factor; Stephen G Jenkins; David P Calfee
Journal:  Infect Control Hosp Epidemiol       Date:  2008-12       Impact factor: 3.254
  6 in total
  4 in total

1.  Point prevalence of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae in Maryland.

Authors:  J Kristie Johnson; Lucy E Wilson; Licheng Zhao; Katherine Richards; Kerri A Thom; Anthony D Harris
Journal:  Infect Control Hosp Epidemiol       Date:  2014-04       Impact factor: 3.254

2.  The Molecular and Clinical Epidemiology of Extended-Spectrum Cephalosporin- and Carbapenem-Resistant Enterobacteriaceae at 4 US Pediatric Hospitals.

Authors:  Danielle M Zerr; Scott J Weissman; Chuan Zhou; Matthew P Kronman; Amanda L Adler; Jessica E Berry; Jaipreet Rayar; Jeff Myers; Wren L Haaland; Carey-Ann D Burnham; Alexis Elward; Jason Newland; Rangaraj Selvarangan; Kaede V Sullivan; Theoklis Zaoutis; Xuan Qin
Journal:  J Pediatric Infect Dis Soc       Date:  2017-11-24       Impact factor: 3.164

3.  Carbapenem-resistant enterobacteriaceae: analyzing knowledge and practice in healthcare providers.

Authors:  Evangeline Thibodeau; Shira Doron; Vito Iacoviello; Jennifer Schimmel; David R Snydman
Journal:  PeerJ       Date:  2014-05-22       Impact factor: 2.984

4.  Vital signs: carbapenem-resistant Enterobacteriaceae.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2013-03-08       Impact factor: 17.586
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.